176 related articles for article (PubMed ID: 17064225)
1. The new era in the treatment of advanced colorectal cancer patients: the role of monoclonal antibodies.
Vincenzi B; Schiavon G; Silletta M; Santini D; Tonini G
Expert Opin Emerg Drugs; 2006 Nov; 11(4):665-83. PubMed ID: 17064225
[TBL] [Abstract][Full Text] [Related]
2. Antibody-based therapies for colorectal cancer.
Chung KY; Saltz LB
Oncologist; 2005 Oct; 10(9):701-9. PubMed ID: 16249350
[TBL] [Abstract][Full Text] [Related]
3. Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer.
Galizia G; Lieto E; De Vita F; Orditura M; Castellano P; Troiani T; Imperatore V; Ciardiello F
Oncogene; 2007 May; 26(25):3654-60. PubMed ID: 17530019
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies in the treatment of colorectal cancer.
Veronese ML; O'Dwyer PJ
Eur J Cancer; 2004 Jun; 40(9):1292-301. PubMed ID: 15177487
[TBL] [Abstract][Full Text] [Related]
5. Recent developments in colorectal cancer treatment by monoclonal antibodies.
Arsene D; Galais MP; Bouhier-Leporrier K; Reimund JM
Expert Opin Biol Ther; 2006 Nov; 6(11):1175-92. PubMed ID: 17049015
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies in the treatment of advanced colorectal cancer.
Capdevila J; Saura C; Macarulla T; Casado E; Ramos FJ; Tabernero J
Eur J Surg Oncol; 2007 Dec; 33 Suppl 2():S24-34. PubMed ID: 17981431
[TBL] [Abstract][Full Text] [Related]
7. Targeted therapy in colorectal cancer.
Rajpal S; Venook AP
Clin Adv Hematol Oncol; 2006 Feb; 4(2):124-32. PubMed ID: 16728921
[TBL] [Abstract][Full Text] [Related]
8. Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer.
Tappenden P; Jones R; Paisley S; Carroll C
Health Technol Assess; 2007 Mar; 11(12):1-128, iii-iv. PubMed ID: 17346499
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor monoclonal antibodies for the treatment of metastatic colorectal cancer.
Jean GW; Shah SR
Pharmacotherapy; 2008 Jun; 28(6):742-54. PubMed ID: 18503402
[TBL] [Abstract][Full Text] [Related]
10. Targeted therapy in advanced colorectal cancer: more data, more questions.
Ochenduszko SL; Krzemieniecki K
Anticancer Drugs; 2010 Sep; 21(8):737-48. PubMed ID: 20631611
[TBL] [Abstract][Full Text] [Related]
11. [Chemotherapy for metastatic colorectal cancer].
Iwasa S; Shimada Y
Gan To Kagaku Ryoho; 2008 Sep; 35(9):1467-74. PubMed ID: 18799899
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor: pathway, therapies, and pipeline.
Goffin JR; Zbuk K
Clin Ther; 2013 Sep; 35(9):1282-303. PubMed ID: 24054705
[TBL] [Abstract][Full Text] [Related]
13. [Interpretation of the updates of NCCN 2017 version 1.0 guideline for colorectal cancer].
Chen G
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):28-33. PubMed ID: 28105616
[TBL] [Abstract][Full Text] [Related]
14. Current progress in targeted therapy for colorectal cancer.
Ortega J; Vigil CE; Chodkiewicz C
Cancer Control; 2010 Jan; 17(1):7-15. PubMed ID: 20010514
[TBL] [Abstract][Full Text] [Related]
15. First-line use of anti-epidermal growth factor receptor monoclonal antibodies in metastatic colorectal cancer.
Lee JJ; Chu E
Clin Colorectal Cancer; 2007 Oct; 6 Suppl 2():S42-6. PubMed ID: 18021486
[TBL] [Abstract][Full Text] [Related]
16. Integration of novel agents in the treatment of colorectal cancer.
Iqbal S; Lenz HJ
Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S32-9. PubMed ID: 15309512
[TBL] [Abstract][Full Text] [Related]
17. Targeted therapies in the treatment of colorectal cancers.
Alekshun T; Garrett C
Cancer Control; 2005 Apr; 12(2):105-10. PubMed ID: 15855893
[TBL] [Abstract][Full Text] [Related]
18. New target agents in the treatment of colorectal cancer patients.
Tonini G; Schiavon G; Vincenzi B; Santini D
Expert Opin Drug Discov; 2007 Jun; 2(6):861-71. PubMed ID: 23489003
[TBL] [Abstract][Full Text] [Related]
19. Current opinion on optimal treatment for colorectal cancer.
Price TJ; Segelov E; Burge M; Haller DG; Ackland SP; Tebbutt NC; Karapetis CS; Pavlakis N; Sobrero AF; Cunningham D; Shapiro JD
Expert Rev Anticancer Ther; 2013 May; 13(5):597-611. PubMed ID: 23617351
[TBL] [Abstract][Full Text] [Related]
20. Targeted drugs in metastatic colorectal cancer with special emphasis on guidelines for the use of bevacizumab and cetuximab: an Acta Oncologica expert report.
Nygren P; Sørbye H; Osterlund P; Pfeiffer P
Acta Oncol; 2005; 44(3):203-17. PubMed ID: 16076691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
